Pfizer Inc
(MIL:1PFE)
€
24.62
-0.33 (-1.32%)
Market Cap: 140.00 Bil
Enterprise Value: 193.63 Bil
PE Ratio: 34.77
PB Ratio: 1.58
GF Score: 59/100 Pfizer Inc at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 01:10PM GMT
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Okay. Great. Thank you. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and I have great pleasure to start with Dr. Dave Denton from Pfizer.
David M. Denton
Pfizer Inc. - CFO & Executive VP
I love it.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
And Chris Stevo from Pfizer. So Dave is the CFO of the Pfizer and he recently started in May of this year.
David M. Denton
Pfizer Inc. - CFO & Executive VP
Yes, exactly. Exactly.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
And Chris, I think it is almost a year for you.
Christopher J. Stevo;
Pfizer Inc. - Senior VP & Chief IR Officer
Correct. Just over a year actually.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot